diabetes care devices market
06 Jan 2022  |  Global
Growth Strategies in an Increasingly Competitive and Digitalized Environment
The diabetes industry offers significant growth opportunities, given the rising prevalence of this disease condition. However, the devices space comprising self-monitoring of blood glucose (SMBG, or glucometer), continuous glucose monitors (CGMs), insulin pens, and insulin pumps are facing unprecedented threats and challenges, some of which are def...
Special Price $2,082.50 save 15 %
07 Feb 2020  |  Asia Pacific
The Professional Testing Segment will See a High Growth Rate of 10% in this High-cost Device Market
Diabetes is a growing global concern, with more than 425 million people suffering the world over. Thailand is no exception. It has a high prevalence of about 8%; there were an estimated 4.25 million diabetics in the country in 2018. Unfortunately, only about 56% of this population is actually diagnosed, meaning almost half of those diabetics are di...
07 Feb 2020  |  Asia Pacific
Service Models that Address Affordability are the Preferred Models in this Cost-sensitive Market
Diabetes is a growing concern globally, with more than 425 million people suffering the world over. Malaysia is no exception. It has a very high prevalence of about 16%; there were an estimated 3.57 million diabetics in the country in 2018. Unfortunately, only about 50% of this population is actually diagnosed, meaning half of those diabetics are d...
06 Feb 2020  |  Asia Pacific
Universal Healthcare Coverage will Help Boost the Low Diagnosis Rate of 33% and Unlock Market Potential
Diabetes is a growing concern globally, with more than 425 million people suffering the world over. The Philippines is no exception. It has a high prevalence of diabetes, of about 6% or an estimated 3.8 million diabetics, in 2018. Unfortunately, only about 33% of this population is actually diagnosed, meaning more than two-thirds of those diabetic...
06 Feb 2020  |  Asia Pacific
Low Diagnosis Rate of 26% Presents Opportunities to Unlock and Tap in to a Large Market
Diabetes is a growing concern, with more than 425 million people suffering the world over. Indonesia is no exception. It has high prevalence, of about 7% or an estimated 10.48 million diabetics in the country in 2018. Unfortunately, only about 26% of this population is actually diagnosed, meaning over two-thirds of those diabetics are diagnosed onl...
31 Mar 2017  |  North America
Innovations to Disrupt Diabetes Wellness, Diagnosis, Monitoring, and Therapy
Diabetes management is on the verge of being disrupted by innovative technologies such as artificial pancreas, non-invasive glucose monitoring sensors, wearables, apps, and inhalable insulin. This research study captures all the innovative developments across the segments of wellness, diagnosis, monitoring, and therapy of the diabetes care continuu...
02 Mar 2017  |  Global
Novel Biomarker Research is Likely to Transform the Future of Obesity and Diabetes Management
Obesity and diabetes are areas of growing concern across both, developed and developing countries. The rising geriatric population is likely to contribute to an increased prevalence of obesity and diabetes across the global landscape. Biomarker research is likely to facilitate the emergence of novel tools that may be useful for enhanced management ...
30 Mar 2016  |  Global
Global Diabetes Epidemic Adds Urgency to R&D Initiatives, Inhalable and Transdermal Delivery on Upward Trajectory
Diabetes has exhibited dramatic increases during the past decade, registering a global prevalence of 9% among adults aged 18 years and older, and is projected to be the 7th-leading cause of death by 2030. The most popular treatment for type 1 diabetes mellitus (T1DM) is multiple daily insulin (MDI) injections. However, researchers globally are work...
01 Jul 2015  |  North America
Constricting Reimbursement Policies Restrain Market Growth
The diabetes diagnostics markets in the United States and Europe have been in a mature stage for many years. Growth is sustained due to the high prevalence of diabetes in both regions. The segments covered in the study are self-monitoring of blood glucose (SMBG), point-of-care testing (POCT), and lab-based HbA1c testing. The emerging market of non-...
Special Price $5,212.50 save 25 %
17 Mar 2015  |  Global
Future Options for End Users
The global diabetes drug delivery market is mainly divided into injectable drug delivery and oral drug delivery systems. The trend will continue in 2015, as four major products: Afrezza (inhalable drug delivery product of MannKind distributed by Sanofi), Tanzeum (injectable pen), Xigduo XR (oral), and Xultophy (injectable pen) enter the US and Euro...
28 Apr 2014  |  North America
The marketed and development product landscape for diabetes therapeutics is becoming crowded with multiple products with little differentiation. However, there is still ample room for growth through the introduction of novel therapies that fill therapeutic gaps left by available products. Comprehensive information on market background and global ...
Special Price $2,962.50 save 25 %
19 Dec 2013  |  Global
Innovative Drugs to Launch in the Next 3 Years, Impacting the Insulin and Non-insulin Markets
Biomarkers are no longer mere tools used to measure the criteria of a biological process characteristic. They are being increasingly used in patient stratification and customised medical interventions. This research service presents an overview and analysis of the global biomarker market. It provides revenue forecasts for biomarker on technological...
Special Price $1,837.50 save 25 %
23 Sep 2013  |  Asia Pacific
Market Opportunities for Differentiated Therapeutics
The packaging industry plays a major role in the pharmaceutical market. It not only provides containment and drug safety, but also ensures identity, convenience of handling, and delivery. It needs to balance complex considerations. Pharmaceutical packaging firms are some of the industrys most innovative companies, as has been evident in the last 1...
18 Mar 2013  |  South Asia, Middle East & North Africa
This research service studies the Indian Diabetes market. It provides the number of Type 1 and Type 2 diabetic patients in India across different age groups and forecasts these numbers up to 2030. It provides a detailed analysis of the two major segments of the market, the insulin market segment and the anti-diabetic medications segment, which incl...
03 Oct 2012  |  South Asia, Middle East & North Africa
Diabetes, an Apparent Epidemic in India: Opportunities for Pharmaceutical Companies
This research service presents an overview of the diabetes therapeutic market in India. It quantifies the market size and provides growth forecasts of the market from 2010 to 2016. It provides an in-depth analysis of key treatment challenges of diabetes management, market drivers and restraints, and how they affect the market dynamics during the fo...
13 Jul 2012  |  Europe
Growing Diabetes Prevalence Drives Demand
The aim of this research service is to analyse the diabetes diagnostics market in Europe and provide strategic recommendations and conclusions for the success of its participants. The main objective of this research service is to establish an understanding of the key diabetes diagnostics market segments (laboratory-based HbA1C diagnostics, SMBG and...
22 Feb 2012  |  North America
This research service presents a marketed and pipeline analysis of the U.S. type 2 diabetes mellitus market. According to the 2011 National Diabetes Fact Sheet, 25.8 million children and adults (or 8.3 percent of the population) in the United States suffer from diabetes. Type 2 diabetes mellitus is the most common form of diabetes; approximately 90...
Special Price $1,125.00 save 25 %
11 Sep 2011  |  Europe
European Diabetes Therapeutics Market - How Far Would it Go:New Classes of Drugs to Emerge by 2014
The research study aims to thoroughly assess and analyse the diabetes therapeutics market, market and technology trends, in European countries and provide strategic recommendations for the success of the market participants. Diabetes is the fastest growing market in the pharmaceutical industry. This study is focussed on two segments Insulin and Non...
19 Aug 2011  |  North America
U.S. Diabetes Injection Pens' Features
A majority of type 2 diabetics currently use Lantus SoloSTAR Pen. Most of them use prefilled injection pens that are entirely disposable. These pens are more convenient to use for most patients with busy lifestyles, as they come pre-filled with insulin/medication. Easy push-button injection, transparent cartridge, and a window showing injection is ...
14 Mar 2011  |  North America
2010 U.S. Type 2 Diabetes Patients' Choice: Awareness, Usage, and Preferences of Injection Pens
Type 2 diabetes is the most common form of diabetes. It is a chronic disease marked by high levels of glucose in the blood. The primary goal to treat type 2 diabetes is diet and exercise. However, if diet and exercise does not help maintain normal glucose levels, physicians may prescribe medication. A sample size of 1,002 adult type 2 diabetes p...